Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NEOS

Neos Therapeutics (NEOS) Stock Price, News & Analysis

Neos Therapeutics logo

About Neos Therapeutics Stock (NASDAQ:NEOS)

Advanced Chart

Key Stats

Today's Range
$1.06
$1.18
50-Day Range
$0.77
$1.18
52-Week Range
$0.45
$1.68
Volume
15.01 million shs
Average Volume
7.44 million shs
Market Capitalization
$57.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NEOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NEOS Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
MCET MultiCell Technologies, Inc.
NEOS/USD - NeosCoin US Dollar
Cara Therapeutics, Inc. (CARA)
See More Headlines

NEOS Stock Analysis - Frequently Asked Questions

Neos Therapeutics, Inc. (NASDAQ:NEOS) released its quarterly earnings results on Monday, November, 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.05. The firm had revenue of $12.54 million for the quarter.

Neos Therapeutics (NEOS) raised $60 million in an initial public offering on Thursday, July 23rd 2015. The company issued 4,000,000 shares at $14.00-$16.00 per share. UBS Investment Bank, BMO Capital Markets and RBC Capital Markets served as the underwriters for the IPO and JMP Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neos Therapeutics investors own include TherapeuticsMD (TXMD), Onconova Therapeutics (ONTX), Adamis Pharmaceuticals (ADMP), Acasti Pharma (ACST), SCYNEXIS (SCYX), Corbus Pharmaceuticals (CRBP) and AVEO Pharmaceuticals (AVEO).

Company Calendar

Last Earnings
11/09/2020
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NEOS
Fax
N/A
Employees
213
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.90 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$64.65 million
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-9.58

Miscellaneous

Free Float
N/A
Market Cap
$57.22 million
Optionable
Optionable
Beta
1.50
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:NEOS) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners